[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-001", "question": "A 58-year-old man with a history of hypertrophic cardiomyopathy presents with recurrent syncope. Genetic testing reveals a mutation in the MYH7 gene. Echocardiography shows asymmetric septal hypertrophy with a left ventricular outflow tract gradient of 80 mmHg at rest. Despite optimal medical therapy with beta-blockers, he continues to experience symptoms. What is the most appropriate next step in management?", "options": ["Implantable cardioverter-defibrillator placement", "Septal myectomy", "Alcohol septal ablation", "Dual-chamber pacing", "Mavacamten initiation"], "answer": "E", "answer_index": 4, "explanation": "Mavacamten is the most appropriate next step as it is a cardiac myosin inhibitor specifically indicated for symptomatic obstructive hypertrophic cardiomyopathy refractory to beta-blockers, targeting the underlying pathophysiology. Septal myectomy and alcohol septal ablation are invasive options reserved for cases not responding to medical therapy, but mavacamten offers a non-invasive alternative with recent evidence supporting its use before procedural interventions. Implantable cardioverter-defibrillator and dual-chamber pacing address arrhythmic risks but not the outflow obstruction directly.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (multiple answers defensible)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: Symptomatic obstructive HCM (LVOT gradient 80 mmHg) despite “optimal medical therapy with beta-blockers”; MYH7 mutation; recurrent syncope (high-risk symptom). The question asks for the most appropriate next step in management.\\nThe keyed answer (mavacamten) is reasonable given contemporary data (e.g., EXPLORER-HCM) and its indication for symptomatic obstructive HCM refractory to beta‑blockers. However, recurrent syncope in HCM represents a major sudden cardiac death risk marker. Implantable cardioverter‑defibrillator (ICD) placement (choice A) is guideline‑supported as primary prevention in high‑risk patients and directly addresses the potentially lethal manifestation described. The stem does not state that risk stratification has been completed or that ICD indications are absent, so both A (ICD for syncope) and E (mavacamten for obstruction) are defensible “next steps.” Thus a unique best choice cannot be identified from the given information.\\nMedical accuracy: The descriptions of mavacamten, septal reduction therapies, ICD, and pacing are broadly accurate, though characterization of septal myectomy/ablation as “reserved” only after mavacamten is somewhat oversimplified.\\nMinimal fix: Explicitly state that sudden death risk has been addressed (e.g., “He has no additional ICD indications and has declined ICD placement”) or remove ICD as an option to make E uniquely best.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (multiple answers defensible)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: Symptomatic obstructive HCM (LVOT gradient 80 mmHg) despite “optimal medical therapy with beta-blockers”; MYH7 mutation; recurrent syncope (high-risk symptom). The question asks for the most appropriate next step in management.\nThe keyed answer (mavacamten) is reasonable given contemporary data (e.g., EXPLORER-HCM) and its indication for symptomatic obstructive HCM refractory to beta‑blockers. However, recurrent syncope in HCM represents a major sudden cardiac death risk marker. Implantable cardioverter‑defibrillator (ICD) placement (choice A) is guideline‑supported as primary prevention in high‑risk patients and directly addresses the potentially lethal manifestation described. The stem does not state that risk stratification has been completed or that ICD indications are absent, so both A (ICD for syncope) and E (mavacamten for obstruction) are defensible “next steps.” Thus a unique best choice cannot be identified from the given information.\nMedical accuracy: The descriptions of mavacamten, septal reduction therapies, ICD, and pacing are broadly accurate, though characterization of septal myectomy/ablation as “reserved” only after mavacamten is somewhat oversimplified.\nMinimal fix: Explicitly state that sudden death risk has been addressed (e.g., “He has no additional ICD indications and has declined ICD placement”) or remove ICD as an option to make E uniquely best.\n", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-002", "question": "A 72-year-old woman with Parkinson's disease develops sudden onset of severe headache, vomiting, and left-sided hemiparesis. MRI reveals a right thalamic hemorrhage with intraventricular extension. She is on carbidopa-levodopa and has a history of orthostatic hypotension. What is the most likely underlying mechanism contributing to this event?", "options": ["Cerebral amyloid angiopathy", "Hypertensive vasculopathy", "Levodopa-induced vasospasm", "Orthostatic hypotension-related watershed infarction", "Dopaminergic therapy-associated coagulopathy"], "answer": "B", "answer_index": 1, "explanation": "Hypertensive vasculopathy is the most likely mechanism, as chronic hypertension in elderly patients with Parkinson's often leads to small vessel disease and thalamic hemorrhages. Cerebral amyloid angiopathy typically affects cortical regions, not deep structures like the thalamus. Levodopa does not directly cause vasospasm or coagulopathy, and while orthostatic hypotension is common, it more often results in ischemic rather than hemorrhagic events.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 72-year-old, sudden severe headache, vomiting, focal deficit (left hemiparesis); MRI shows right thalamic hemorrhage with intraventricular extension; elderly with presumed chronic hypertension (common in this demographic, though not explicitly stated). Deep intracerebral hemorrhage in the thalamus is classically due to hypertensive vasculopathy involving small penetrating arteries (e.g., thalamoperforators).\\nOption B fits this pattern best. Cerebral amyloid angiopathy (A) typically causes lobar cortical/subcortical hemorrhages, not deep thalamic bleeds. Levodopa-induced vasospasm (C) is not an established mechanism. Orthostatic hypotension (D) is associated with watershed ischemic infarcts, not deep hemorrhage. Dopaminergic therapy-associated coagulopathy (E) is not a recognized entity.\\nMain logical issue(s): Mild assumption that the patient has chronic hypertension, but this is strongly implied by age and classic location of bleed; options are clearly discriminable, so a single best answer exists.\\nMain medical accuracy issue(s): Minor—phrase “often leads” about hypertension in Parkinson’s is somewhat generic but not misleading.\\nMinimal fix: Explicitly state a history of long-standing poorly controlled hypertension in the stem to remove any residual ambiguity about the underlying mechanism.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 72-year-old, sudden severe headache, vomiting, focal deficit (left hemiparesis); MRI shows right thalamic hemorrhage with intraventricular extension; elderly with presumed chronic hypertension (common in this demographic, though not explicitly stated). Deep intracerebral hemorrhage in the thalamus is classically due to hypertensive vasculopathy involving small penetrating arteries (e.g., thalamoperforators).\nOption B fits this pattern best. Cerebral amyloid angiopathy (A) typically causes lobar cortical/subcortical hemorrhages, not deep thalamic bleeds. Levodopa-induced vasospasm (C) is not an established mechanism. Orthostatic hypotension (D) is associated with watershed ischemic infarcts, not deep hemorrhage. Dopaminergic therapy-associated coagulopathy (E) is not a recognized entity.\nMain logical issue(s): Mild assumption that the patient has chronic hypertension, but this is strongly implied by age and classic location of bleed; options are clearly discriminable, so a single best answer exists.\nMain medical accuracy issue(s): Minor—phrase “often leads” about hypertension in Parkinson’s is somewhat generic but not misleading.\nMinimal fix: Explicitly state a history of long-standing poorly controlled hypertension in the stem to remove any residual ambiguity about the underlying mechanism.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-003", "question": "A 45-year-old man with type 1 diabetes mellitus presents with recurrent hypoglycemia despite dose adjustments. He has a history of autoimmune thyroiditis and vitiligo. Laboratory evaluation shows low morning cortisol and elevated ACTH. What is the most appropriate confirmatory test for the suspected diagnosis?", "options": ["Cosyntropin stimulation test", "Insulin tolerance test", "21-Hydroxylase antibody assay", "Adrenal CT scan", "Metyrapone test"], "answer": "C", "answer_index": 2, "explanation": "21-Hydroxylase antibody assay is the most appropriate confirmatory test for autoimmune adrenalitis in the context of polyglandular autoimmune syndrome type 2, given the patient's other autoimmune conditions. Cosyntropin stimulation test assesses adrenal reserve but does not confirm etiology. Insulin tolerance and metyrapone tests evaluate the hypothalamic-pituitary-adrenal axis but are less specific for autoimmune causes, and adrenal CT is imaging that may show atrophy but not confirm autoimmunity.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible, with element of U – underspecified)\\nVerdict on keyed answer: Not uniquely determinable; key likely misfocused on etiology rather than standard diagnostic confirmation\\n\\nKey stem clues: Type 1 diabetes, autoimmune thyroiditis, vitiligo → polyglandular autoimmunity; recurrent hypoglycemia; low morning cortisol with elevated ACTH → primary adrenal insufficiency (autoimmune Addison disease). Question: “most appropriate confirmatory test for the suspected diagnosis.” On boards, the standard confirmatory test for adrenal insufficiency is the cosyntropin (ACTH) stimulation test, not an antibody assay.\\n\\nLogical issue: The stem asks to confirm the *diagnosis* of primary adrenal insufficiency already suggested by a single low morning cortisol value (which is not by itself confirmatory). Cosyntropin is classically the confirmatory test. The keyed answer (21-hydroxylase antibody assay) instead confirms the *autoimmune etiology*, which is a secondary question and typically done after establishing AI. Both A and C are defensible depending on interpretation of “confirmatory,” creating ambiguity.\\n\\nMedical accuracy: Content is generally accurate, but the priority of cosyntropin for diagnostic confirmation is misapplied.\\n\\nMinimal fix: Change stem to “What is the most appropriate test to confirm the autoimmune etiology of his primary adrenal insufficiency?” so that C is uniquely correct.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible, with element of U – underspecified)\nVerdict on keyed answer: Not uniquely determinable; key likely misfocused on etiology rather than standard diagnostic confirmation\n\nKey stem clues: Type 1 diabetes, autoimmune thyroiditis, vitiligo → polyglandular autoimmunity; recurrent hypoglycemia; low morning cortisol with elevated ACTH → primary adrenal insufficiency (autoimmune Addison disease). Question: “most appropriate confirmatory test for the suspected diagnosis.” On boards, the standard confirmatory test for adrenal insufficiency is the cosyntropin (ACTH) stimulation test, not an antibody assay.\n\nLogical issue: The stem asks to confirm the *diagnosis* of primary adrenal insufficiency already suggested by a single low morning cortisol value (which is not by itself confirmatory). Cosyntropin is classically the confirmatory test. The keyed answer (21-hydroxylase antibody assay) instead confirms the *autoimmune etiology*, which is a secondary question and typically done after establishing AI. Both A and C are defensible depending on interpretation of “confirmatory,” creating ambiguity.\n\nMedical accuracy: Content is generally accurate, but the priority of cosyntropin for diagnostic confirmation is misapplied.\n\nMinimal fix: Change stem to “What is the most appropriate test to confirm the autoimmune etiology of his primary adrenal insufficiency?” so that C is uniquely correct.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-004", "question": "A 60-year-old smoker with COPD presents with progressive dyspnea and hemoptysis. CT chest reveals a 2 cm spiculated nodule in the right upper lobe with mediastinal lymphadenopathy. Bronchoscopy with biopsy confirms squamous cell carcinoma. PET-CT shows no distant metastases. What is the most appropriate initial management?", "options": ["Stereotactic body radiotherapy", "Surgical lobectomy with lymph node dissection", "Concurrent chemoradiotherapy", "Immune checkpoint inhibitor monotherapy", "Epidermal growth factor receptor tyrosine kinase inhibitor"], "answer": "B", "answer_index": 1, "explanation": "Surgical lobectomy with lymph node dissection is the most appropriate for stage I squamous cell lung cancer in a patient with adequate pulmonary reserve, offering the best chance for cure. Stereotactic body radiotherapy is an alternative for non-surgical candidates, but this patient has no contraindications mentioned. Chemoradiotherapy and targeted therapies are for more advanced stages or specific molecular profiles not indicated here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U (underspecified, leading to possible M)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: 60-year-old smoker with COPD, biopsy-proven squamous cell carcinoma, 2 cm spiculated right upper lobe nodule, mediastinal lymphadenopathy, PET-CT without distant metastases. Mediastinal nodes upstage disease beyond stage I; at minimum this suggests stage III disease if nodes are involved. The explanation labels this as “stage I,” which conflicts with the described mediastinal lymphadenopathy.\\nMain logical issues: The presence of mediastinal lymphadenopathy suggests N2/N3 disease, where concurrent chemoradiotherapy (option C) would typically be standard initial management if unresectable. Whether disease is resectable (single-station N2, good pulmonary reserve) versus unresectable is not specified, yet that distinction is crucial to choosing between lobectomy and chemoradiation. Thus the stem omits key staging/resectability data, and the explanation misclassifies the stage, making the key not clearly superior.\\nMain medical accuracy issues: Misstating this as stage I with mediastinal lymphadenopathy is inaccurate. Otherwise, general treatment descriptions are reasonable.\\nMinimal fix: Clarify that mediastinal nodes are negative (e.g., “no mediastinal lymphadenopathy”) or explicitly state “no nodal involvement, clinical stage I” to support lobectomy as clearly best.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (underspecified, leading to possible M)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: 60-year-old smoker with COPD, biopsy-proven squamous cell carcinoma, 2 cm spiculated right upper lobe nodule, mediastinal lymphadenopathy, PET-CT without distant metastases. Mediastinal nodes upstage disease beyond stage I; at minimum this suggests stage III disease if nodes are involved. The explanation labels this as “stage I,” which conflicts with the described mediastinal lymphadenopathy.\nMain logical issues: The presence of mediastinal lymphadenopathy suggests N2/N3 disease, where concurrent chemoradiotherapy (option C) would typically be standard initial management if unresectable. Whether disease is resectable (single-station N2, good pulmonary reserve) versus unresectable is not specified, yet that distinction is crucial to choosing between lobectomy and chemoradiation. Thus the stem omits key staging/resectability data, and the explanation misclassifies the stage, making the key not clearly superior.\nMain medical accuracy issues: Misstating this as stage I with mediastinal lymphadenopathy is inaccurate. Otherwise, general treatment descriptions are reasonable.\nMinimal fix: Clarify that mediastinal nodes are negative (e.g., “no mediastinal lymphadenopathy”) or explicitly state “no nodal involvement, clinical stage I” to support lobectomy as clearly best.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-005", "question": "A 35-year-old woman in the emergency department presents with chest pain, palpitations, and diaphoresis after using cocaine. ECG shows ST-segment elevation in leads V2-V4. Troponin is elevated. Coronary angiography reveals a thrombus in the left anterior descending artery with no underlying atherosclerosis. What is the most appropriate immediate management?", "options": ["Intracoronary thrombolysis", "Percutaneous coronary intervention with stenting", "Systemic anticoagulation with heparin", "Glycoprotein IIb/IIIa inhibitor infusion", "Aspiration thrombectomy"], "answer": "E", "answer_index": 4, "explanation": "Aspiration thrombectomy is the most appropriate for cocaine-induced myocardial infarction due to vasospasm and thrombus without atherosclerosis, allowing removal of the clot while minimizing vessel trauma. Stenting is unnecessary without plaque, and thrombolysis carries bleeding risks. Anticoagulation and glycoprotein inhibitors are adjunctive but not primary interventions for isolated thrombus.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N (no answer defensible)\\nVerdict on keyed answer: Not defensible as uniquely best; item appears to test a non–standard-of-care intervention sequence.\\nKey stem clues: Young woman with cocaine use, ST-elevation MI (V2–V4), elevated troponin, cath shows thrombus in LAD with no atherosclerosis. Question: “most appropriate immediate management.” This is already in the cath lab.\\nCurrent standard care for STEMI with identifiable culprit thrombus is primary PCI (balloon angioplasty ± stenting) as the main reperfusion strategy; manual aspiration thrombectomy is not recommended as routine primary therapy and has not shown outcome benefit, per large trials and guidelines. It may be used selectively, but not as the primary, guideline-endorsed “most appropriate immediate” treatment.\\nThus, none of the offered options cleanly match guideline-based first-line management (PCI with appropriate revascularization strategy; if no stent, still balloon angioplasty). Option B (PCI with stenting) is closer to standard care than E, but the stem emphasizes no atherosclerosis, making B debatable; E is clearly not standard of care as primary therapy.\\nMinimal fix: Change keyed answer to B and reword explanation to reflect PCI as primary treatment, with thrombectomy as optional adjunct, or rewrite choices to include “primary PCI with balloon angioplasty ± stenting per angiographic findings.”\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N (no answer defensible)\nVerdict on keyed answer: Not defensible as uniquely best; item appears to test a non–standard-of-care intervention sequence.\nKey stem clues: Young woman with cocaine use, ST-elevation MI (V2–V4), elevated troponin, cath shows thrombus in LAD with no atherosclerosis. Question: “most appropriate immediate management.” This is already in the cath lab.\nCurrent standard care for STEMI with identifiable culprit thrombus is primary PCI (balloon angioplasty ± stenting) as the main reperfusion strategy; manual aspiration thrombectomy is not recommended as routine primary therapy and has not shown outcome benefit, per large trials and guidelines. It may be used selectively, but not as the primary, guideline-endorsed “most appropriate immediate” treatment.\nThus, none of the offered options cleanly match guideline-based first-line management (PCI with appropriate revascularization strategy; if no stent, still balloon angioplasty). Option B (PCI with stenting) is closer to standard care than E, but the stem emphasizes no atherosclerosis, making B debatable; E is clearly not standard of care as primary therapy.\nMinimal fix: Change keyed answer to B and reword explanation to reflect PCI as primary treatment, with thrombectomy as optional adjunct, or rewrite choices to include “primary PCI with balloon angioplasty ± stenting per angiographic findings.”", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-006", "question": "A 68-year-old man with atrial fibrillation on anticoagulation develops acute right-sided weakness. CT head shows no hemorrhage, and MRI confirms acute ischemic stroke in the left middle cerebral artery territory. He is within 4.5 hours of symptom onset. What is the most critical factor determining eligibility for intravenous thrombolysis?", "options": ["International normalized ratio value", "Time since last anticoagulant dose", "Presence of atrial fibrillation", "Stroke severity on NIHSS scale", "Reversal agent availability"], "answer": "A", "answer_index": 0, "explanation": "The international normalized ratio value is the most critical, as thrombolysis is contraindicated if INR >1.7 in patients on vitamin K antagonists to avoid hemorrhagic complications. Time since last dose affects coagulopathy but INR directly measures it. Atrial fibrillation and stroke severity influence overall management but not thrombolysis eligibility directly, and reversal agents are for bleeding, not pre-thrombolysis.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 68-year-old man with atrial fibrillation “on anticoagulation,” acute ischemic MCA stroke, within 4.5 hours, CT shows no hemorrhage. The question asks: in an anticoagulated patient, what is the most critical factor determining IV thrombolysis eligibility?\\nThe major specific contraindication relates to the degree of anticoagulation. For vitamin K antagonists, current guidelines use INR >1.7 as a cutoff for IV alteplase exclusion. Among the listed options, INR value is the direct, objective measure of anticoagulation effect and therefore is the most critical determinant. Time since last dose (B) matters but is an indirect and drug-dependent surrogate; in DOACs, specific anti–factor assays or timing may be more relevant, but the item’s explanation clearly focuses on warfarin/INR. Atrial fibrillation (C) supports a cardioembolic source but does not determine tPA eligibility. Stroke severity (D) influences risk–benefit but is not the primary eligibility factor in anticoagulated patients. Reversal agent availability (E) is for active bleeding, not a prerequisite for tPA.\\nMain medical issue: Narrowed to warfarin/INR without stating anticoagulant type, but still acceptable. Minimal fix: Specify he is on warfarin to align fully with the INR-based rationale.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 68-year-old man with atrial fibrillation “on anticoagulation,” acute ischemic MCA stroke, within 4.5 hours, CT shows no hemorrhage. The question asks: in an anticoagulated patient, what is the most critical factor determining IV thrombolysis eligibility?\nThe major specific contraindication relates to the degree of anticoagulation. For vitamin K antagonists, current guidelines use INR >1.7 as a cutoff for IV alteplase exclusion. Among the listed options, INR value is the direct, objective measure of anticoagulation effect and therefore is the most critical determinant. Time since last dose (B) matters but is an indirect and drug-dependent surrogate; in DOACs, specific anti–factor assays or timing may be more relevant, but the item’s explanation clearly focuses on warfarin/INR. Atrial fibrillation (C) supports a cardioembolic source but does not determine tPA eligibility. Stroke severity (D) influences risk–benefit but is not the primary eligibility factor in anticoagulated patients. Reversal agent availability (E) is for active bleeding, not a prerequisite for tPA.\nMain medical issue: Narrowed to warfarin/INR without stating anticoagulant type, but still acceptable. Minimal fix: Specify he is on warfarin to align fully with the INR-based rationale.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-007", "question": "A 52-year-old woman with acromegaly undergoes transsphenoidal surgery. Postoperatively, she develops polyuria with urine output exceeding 300 mL/hour. Serum sodium is 148 mEq/L, and urine specific gravity is 1.002. What is the most appropriate initial pharmacologic intervention?", "options": ["Desmopressin acetate", "Hydrochlorothiazide", "Demeclocycline", "Tolvaptan", "Conivaptan"], "answer": "A", "answer_index": 0, "explanation": "Desmopressin acetate is the most appropriate for central diabetes insipidus following pituitary surgery, replacing deficient antidiuretic hormone to concentrate urine. Hydrochlorothiazide is used for nephrogenic diabetes insipidus, not central. Demeclocycline and vasopressin antagonists like tolvaptan or conivaptan are for syndrome of inappropriate antidiuretic hormone, which would worsen hypernatremia here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Recent transsphenoidal pituitary surgery; acute onset of marked polyuria (>300 mL/h); hypernatremia (Na 148 mEq/L); very dilute urine (specific gravity 1.002). These findings are classic for acute central diabetes insipidus from loss of ADH secretion after pituitary surgery. The question asks for the most appropriate initial pharmacologic intervention.\\nDesmopressin (A) directly replaces deficient ADH, is first-line for central DI, and is standard initial pharmacologic treatment in this exact postoperative setting. Hydrochlorothiazide (B) is used in chronic nephrogenic DI and is not first-line for acute postoperative central DI. Demeclocycline (C) and vasopressin receptor antagonists tolvaptan (D) and conivaptan (E) are used for SIADH and would worsen this patient’s hypernatremia and free-water loss. No other option is reasonably competitive as “best.”\\nMedical accuracy is high and aligned with standard endocrinology and perioperative care. A minor nuance (initial assessment of volume status and cautious free-water replacement) is not asked, but that does not affect the pharmacologic best answer.\\nMinimal fix: Add “develops polyuria within 24 hours postoperatively” to emphasize acute central DI timing (clarity only; not strictly necessary).\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Recent transsphenoidal pituitary surgery; acute onset of marked polyuria (>300 mL/h); hypernatremia (Na 148 mEq/L); very dilute urine (specific gravity 1.002). These findings are classic for acute central diabetes insipidus from loss of ADH secretion after pituitary surgery. The question asks for the most appropriate initial pharmacologic intervention.\nDesmopressin (A) directly replaces deficient ADH, is first-line for central DI, and is standard initial pharmacologic treatment in this exact postoperative setting. Hydrochlorothiazide (B) is used in chronic nephrogenic DI and is not first-line for acute postoperative central DI. Demeclocycline (C) and vasopressin receptor antagonists tolvaptan (D) and conivaptan (E) are used for SIADH and would worsen this patient’s hypernatremia and free-water loss. No other option is reasonably competitive as “best.”\nMedical accuracy is high and aligned with standard endocrinology and perioperative care. A minor nuance (initial assessment of volume status and cautious free-water replacement) is not asked, but that does not affect the pharmacologic best answer.\nMinimal fix: Add “develops polyuria within 24 hours postoperatively” to emphasize acute central DI timing (clarity only; not strictly necessary).", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-008", "question": "A 55-year-old man with idiopathic pulmonary fibrosis presents with acute worsening dyspnea. High-resolution CT shows new ground-glass opacities superimposed on fibrosis. Bronchoalveolar lavage reveals neutrophilia without infection. What is the most appropriate therapeutic approach?", "options": ["High-dose systemic corticosteroids", "Azathioprine addition to regimen", "Pirfenidone dose escalation", "Nintedanib initiation", "Lung transplantation evaluation"], "answer": "A", "answer_index": 0, "explanation": "High-dose systemic corticosteroids are the most appropriate for acute exacerbation of idiopathic pulmonary fibrosis, aiming to suppress inflammation despite limited evidence. Azathioprine is contraindicated due to increased mortality risk. Pirfenidone and nintedanib are antifibrotics for stable disease, not acute flares, and transplantation is for end-stage but not immediate management.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Known idiopathic pulmonary fibrosis; acute worsening dyspnea; HRCT with new bilateral ground-glass opacities on background fibrosis; BAL neutrophilia without evidence of infection. These are classic for acute exacerbation of IPF. Standard management is empiric high‑dose systemic corticosteroids, despite limited RCT evidence, making option A the best available choice.\\nOther options: Azathioprine (B) is now avoided/contraindicated in IPF after increased mortality in PANTHER-IPF. Pirfenidone escalation (C) and nintedanib initiation (D) are chronic antifibrotic therapies for stable/ambulatory disease and are not the primary acute management of an exacerbation. Lung transplantation evaluation (E) is appropriate for advanced IPF but is not the immediate treatment of an acute exacerbation and would usually follow stabilization and depends on candidacy.\\nMain logical issue(s): None significant; stem gives sufficient data to define an acute exacerbation and options are clearly distinguishable. \\nMain medical accuracy issue(s): Minor—guidelines acknowledge weak evidence for steroids, but they remain standard practice, which the explanation notes.\\nMinimal fix: Optionally add “initial” or “immediate” to the stem (“What is the most appropriate initial therapeutic approach?”) to emphasize acute management vs long-term planning.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Known idiopathic pulmonary fibrosis; acute worsening dyspnea; HRCT with new bilateral ground-glass opacities on background fibrosis; BAL neutrophilia without evidence of infection. These are classic for acute exacerbation of IPF. Standard management is empiric high‑dose systemic corticosteroids, despite limited RCT evidence, making option A the best available choice.\nOther options: Azathioprine (B) is now avoided/contraindicated in IPF after increased mortality in PANTHER-IPF. Pirfenidone escalation (C) and nintedanib initiation (D) are chronic antifibrotic therapies for stable/ambulatory disease and are not the primary acute management of an exacerbation. Lung transplantation evaluation (E) is appropriate for advanced IPF but is not the immediate treatment of an acute exacerbation and would usually follow stabilization and depends on candidacy.\nMain logical issue(s): None significant; stem gives sufficient data to define an acute exacerbation and options are clearly distinguishable. \nMain medical accuracy issue(s): Minor—guidelines acknowledge weak evidence for steroids, but they remain standard practice, which the explanation notes.\nMinimal fix: Optionally add “initial” or “immediate” to the stem (“What is the most appropriate initial therapeutic approach?”) to emphasize acute management vs long-term planning.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-009", "question": "A 28-year-old man in the emergency department after a motor vehicle collision has hypotension, tachycardia, and abdominal distension. FAST exam shows free fluid in the abdomen. He is taken to the operating room for exploratory laparotomy, revealing a splenic laceration. What is the most appropriate intraoperative management for a hemodynamically unstable patient?", "options": ["Splenic artery embolization", "Partial splenectomy", "Splenorrhaphy with hemostatic agents", "Total splenectomy", "Non-operative management with observation"], "answer": "D", "answer_index": 3, "explanation": "Total splenectomy is the most appropriate for hemodynamically unstable patients with high-grade splenic injury to rapidly control bleeding and stabilize the patient. Embolization and non-operative management are for stable patients. Partial splenectomy or splenorrhaphy preserve splenic function but are time-consuming and risky in instability.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Young man with blunt abdominal trauma, hypotension, tachycardia, abdominal distension, FAST positive for free fluid, taken for emergent laparotomy where a splenic laceration is found, explicitly described as hemodynamically unstable intraoperatively. In an unstable trauma patient with splenic injury who is already in the OR, rapid definitive hemorrhage control is indicated. Total splenectomy (D) is the most appropriate, time-efficient option and aligns with ATLS/trauma surgery practice for unstable patients with high-grade splenic injury.\\nAlternatives: A (splenic artery embolization) and E (non-operative management) are reserved for hemodynamically stable patients; both conflict with the instability described. B (partial splenectomy) and C (splenorrhaphy) are possible in selected more stable settings but are more time-consuming and technically demanding, not first-line in significant instability.\\nMain logical issue(s): None significant; the stem clearly points to an unstable patient needing rapid control. Some nuance about injury grade is assumed but does not create ambiguity.\\nMain medical accuracy issue(s): None; explanation is consistent with modern trauma guidelines.\\nMinimal fix: Optionally add “high-grade splenic injury with ongoing hemorrhage” to the stem to reinforce the indication for splenectomy.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Young man with blunt abdominal trauma, hypotension, tachycardia, abdominal distension, FAST positive for free fluid, taken for emergent laparotomy where a splenic laceration is found, explicitly described as hemodynamically unstable intraoperatively. In an unstable trauma patient with splenic injury who is already in the OR, rapid definitive hemorrhage control is indicated. Total splenectomy (D) is the most appropriate, time-efficient option and aligns with ATLS/trauma surgery practice for unstable patients with high-grade splenic injury.\nAlternatives: A (splenic artery embolization) and E (non-operative management) are reserved for hemodynamically stable patients; both conflict with the instability described. B (partial splenectomy) and C (splenorrhaphy) are possible in selected more stable settings but are more time-consuming and technically demanding, not first-line in significant instability.\nMain logical issue(s): None significant; the stem clearly points to an unstable patient needing rapid control. Some nuance about injury grade is assumed but does not create ambiguity.\nMain medical accuracy issue(s): None; explanation is consistent with modern trauma guidelines.\nMinimal fix: Optionally add “high-grade splenic injury with ongoing hemorrhage” to the stem to reinforce the indication for splenectomy.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-010", "question": "A 65-year-old woman with rheumatoid arthritis develops shortness of breath. Echocardiography reveals severe mitral regurgitation with a flail leaflet. She has preserved left ventricular function but elevated pulmonary pressures. Coronary angiography is normal. What is the most appropriate intervention?", "options": ["Mitral valve repair", "Mitral valve replacement with bioprosthesis", "Transcatheter edge-to-edge repair", "Medical management with afterload reduction", "Cardiac resynchronization therapy"], "answer": "A", "answer_index": 0, "explanation": "Mitral valve repair is the most appropriate for severe primary mitral regurgitation due to flail leaflet in a surgical candidate, offering better durability and preservation of ventricular function compared to replacement. Transcatheter repair is for high-risk patients or functional regurgitation. Medical management and resynchronization do not address the structural defect.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 65-year-old woman; severe mitral regurgitation; flail leaflet (degenerative/primary MR); preserved LV function; elevated pulmonary pressures; normal coronaries. These features describe severe symptomatic primary MR in a patient who appears to be a reasonable surgical candidate (no mention of prohibitive comorbidities).\\n\\nMost appropriate intervention per guidelines for severe primary MR with flail leaflet and acceptable surgical risk is mitral valve surgery, with repair preferred over replacement when feasible due to better survival, preservation of LV function, and fewer prosthesis-related complications. Thus option A is the single best answer.\\n\\nOption B (replacement) is reserved when repair not feasible; no such constraint is stated. Option C (transcatheter edge-to-edge repair) is for prohibitive/high surgical risk or specific anatomic indications, not suggested here. Option D (medical therapy) is adjunctive and not definitive for severe primary MR with symptoms and pulmonary HTN. Option E (CRT) applies to LV dyssynchrony with reduced EF, not present here.\\n\\nMain medical accuracy issues: None substantive; aligns with current ACC/AHA and ESC valve guidelines.\\n\\nMinimal fix: Explicitly state that she is symptomatic and considered an acceptable surgical candidate to remove any residual ambiguity about intervention choice.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 65-year-old woman; severe mitral regurgitation; flail leaflet (degenerative/primary MR); preserved LV function; elevated pulmonary pressures; normal coronaries. These features describe severe symptomatic primary MR in a patient who appears to be a reasonable surgical candidate (no mention of prohibitive comorbidities).\n\nMost appropriate intervention per guidelines for severe primary MR with flail leaflet and acceptable surgical risk is mitral valve surgery, with repair preferred over replacement when feasible due to better survival, preservation of LV function, and fewer prosthesis-related complications. Thus option A is the single best answer.\n\nOption B (replacement) is reserved when repair not feasible; no such constraint is stated. Option C (transcatheter edge-to-edge repair) is for prohibitive/high surgical risk or specific anatomic indications, not suggested here. Option D (medical therapy) is adjunctive and not definitive for severe primary MR with symptoms and pulmonary HTN. Option E (CRT) applies to LV dyssynchrony with reduced EF, not present here.\n\nMain medical accuracy issues: None substantive; aligns with current ACC/AHA and ESC valve guidelines.\n\nMinimal fix: Explicitly state that she is symptomatic and considered an acceptable surgical candidate to remove any residual ambiguity about intervention choice.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]